18F-fluselenamyl (Washington University)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Name18F-fluselenamyl (Washington University)
Drug Alias Namefluselenamyl-[18F]18F-fluselenamylFluorine-18-fluselenamylfluselenamyl (Washington University)
ClassificationRadiation-emitting products
Mechanisms of ActionBeta amyloid A4 protein modulators
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWashington University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWashington University
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A